Skip to main content
. Author manuscript; available in PMC: 2017 Jul 3.
Published in final edited form as: Leuk Lymphoma. 2015 Feb;56(2):395–400. doi: 10.3109/10428194.2014.918970

Table 1.

Patient groups

SAR103168 (mg/m2)
1.2 1.7 2.4 4.8 9.6 14.4 All
Enrolled population 8 4 5 3 5 4 30
All treated population 8 4 5 3 5 4 29
DLT assessment population 6 3 4 3 5 3 24
Pharmacokinetic population 8 4 5 3 5 4 29
Activity/efficacy population 8 4 4 3 4 2 25